10 Bristol Myers Squibb executives

Six executive vice presidents of Bristol Myers Squibb appear here, holding the CFO, chief medical officer, chief research officer, general counsel, supply chain and digital titles, along with the president of its Cell Therapy Organization, its chief procurement officer and the senior vice presidents for Asia-Pacific and for cardiovascular and immunology commercialization. Partners, suppliers and investors can match a question to the executive whose function covers it.

10 professionals1 companyData retrieved October 7, 2026

Professionals to explore

  1. Al Reba

    LinkedIn

    Experience: Senior Vice President, Cardiovascular & Immunology Commercialization · Bristol Myers Squibb

    $2,693 per 30-minute call

    Al Reba has held Senior Vice President, Cardiovascular & Immunology Commercialization at Bristol Myers Squibb since February 2025. Earlier Bristol Myers Squibb titles include Senior Vice President, US Cardiovascular and Established Brands (2023-2025), Senior Vice President, Worldwide Cardiovascular and Established Brands (2021-2023) and General Manager, Bristol-Myers Squibb Canada (2017-2021), a fit for cardiovascular commercialization questions.

    Is this you? Claim your profile and get paid for calls.

  2. Cari Almo Gallman

    LinkedIn

    Experience: Executive Vice President, General Counsel and Chief Policy Officer · Bristol Myers Squibb

    $4,039 per 30-minute call

    Legal, policy, compliance and corporate affairs titles run through Cari Almo Gallman's record at Bristol Myers Squibb: Executive Vice President, General Counsel and Chief Policy Officer since May 2025, Executive Vice President, Corporate Affairs (2023-2025), Senior Vice President, Chief Compliance and Ethics Officer (2021-2023) and Vice President, Assistant General Counsel, Oncology (2019-2021). Gallman fits legal and policy questions.

    Is this you? Claim your profile and get paid for calls.

  3. Cristian Massacesi

    LinkedIn

    Experience: Executive Vice President, Chief Medical Officer and Head of Development · Bristol Myers Squibb

    $4,711 per 30-minute call

    Late-stage development questions fit Cristian Massacesi, who became Executive Vice President, Chief Medical Officer and Head of Development at Bristol Myers Squibb in July 2025, with a global team working on serious diseases including oncology and neuroscience. Massacesi was Chief Medical Officer & Oncology Chief Development Officer (2021-2025) and Senior Vice President, Head of Late Development Oncology R&D (2019-2021) at AstraZeneca.

    Is this you? Claim your profile and get paid for calls.

  4. David Elkins

    LinkedIn

    Experience: Executive Vice President and Chief Financial Officer, Head of Global Business Operations · Bristol Myers Squibb

    $4,711 per 30-minute call

    David Elkins has been Executive Vice President and Chief Financial Officer, Head of Global Business Operations at Bristol Myers Squibb since November 2019. Elkins describes the CFO role as sitting at the intersection of business and healthcare, helping steer an organization where financial decisions are about patients as well as numbers. The current CFO title makes Elkins the fit for finance and business operations questions.

    Is this you? Claim your profile and get paid for calls.

  5. Greg Meyers

    LinkedIn

    Experience: EVP, Chief Digital & Technology Officer, Member of Executive Committee · Bristol Myers Squibb

    $4,039 per 30-minute call

    Technology partner questions belong with Greg Meyers, EVP, Chief Digital & Technology Officer, Member of Executive Committee at Bristol Myers Squibb since January 2022, after serving as Group Chief Information and Digital Officer (CIO and CDO) at Syngenta Group (2018-2022). Meyers was also Corporate VP and Chief Information Officer (CIO) at Motorola Solutions (2014-2018) and Vice President Technology at Biogen (2009-2014).

    Is this you? Claim your profile and get paid for calls.

  6. Karin Shanahan

    LinkedIn

    Experience: EVP, Chief Supply Chain & Operations Officer · Bristol Myers Squibb

    $2,693 per 30-minute call

    Since June 2025, Karin Shanahan has been EVP, Chief Supply Chain & Operations Officer at Bristol Myers Squibb, and held EVP, Global Product Development and Supply there from 2022 to 2025. Shanahan was SVP, Global Biologics & Sterile Operations at Merck (2018-2022) and SVP & COO, Global Operations at Teva Pharmaceuticals (2013-2018), and describes more than 25 years in biopharma, so manufacturing and supply questions fit.

    Is this you? Claim your profile and get paid for calls.

  7. Lynelle Hoch

    LinkedIn

    Experience: President, Cell Therapy Organization · Bristol Myers Squibb

    $4,039 per 30-minute call

    President, Cell Therapy Organization at Bristol Myers Squibb since November 2023, Lynelle Hoch is a Member of the Bristol Myers Squibb Leadership Team with over 25 years at the company. Hoch was Senior Vice President, Cell Therapy Franchise Lead (2021-2023), General Manager, United Kingdom and Ireland (2019-2021) and Vice President Immuno-Oncology Marketing (2016-2019) there. The fit for cell therapy business questions.

    Is this you? Claim your profile and get paid for calls.

  8. Paula Glickenhaus

    LinkedIn

    Experience: Chief Procurement Officer · Bristol Myers Squibb

    $673 per 30-minute call

    Supplier and sourcing questions suit Paula Glickenhaus, Chief Procurement Officer at Bristol Myers Squibb since November 2023, a C-level operations role also given as Senior Vice President and Chief Procurement Officer. Glickenhaus was Ad Interim NA CPO at Kenvue (2023), Global Head Category Management Strategic Sourcing at Google (2021-2023) and SVP, Global Head Commercial & US Procurement at Novartis (2019-2021).

    Is this you? Claim your profile and get paid for calls.

  9. Robert Plenge

    LinkedIn

    Experience: Executive Vice President, Chief Research Officer, Head of Research · Bristol Myers Squibb

    $4,711 per 30-minute call

    Robert Plenge has been Executive Vice President, Chief Research Officer, Head of Research at Bristol Myers Squibb since July 2023. Plenge also held Senior Vice President and Head of Translational Medicine (2021-2023) and Senior Vice President and Head of Immunology, Cardiovascular, & Fibrosis within R&ED (2019-2023) there, and was Head, Inflammation & Immunology Thematic Center of Excellence (TCoE) Unit at Celgene (2017-2019). A fit for research portfolio questions.

    Is this you? Claim your profile and get paid for calls.

  10. Steve Sugino

    LinkedIn

    Experience: Senior Vice President and General Manager, Asia-Pacific · Bristol Myers Squibb

    $2,356 per 30-minute call

    Asia-Pacific and Japan market questions fit Steve Sugino best: Senior Vice President and General Manager, Asia-Pacific at Bristol Myers Squibb since January 2025, after serving as President and General Manager, Japan there (2023-2024), described as President and Representative Director of BMS' Japan operation. Sugino was President and Representative Director at Amgen (2017-2022).

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

Research and development questions go to Robert Plenge and Cristian Massacesi, and anything about manufacturing, supply or buying goes to Karin Shanahan or Paula Glickenhaus. David Elkins, Cari Almo Gallman and Greg Meyers cover finance, legal and policy, and technology, while Lynelle Hoch, Steve Sugino and Al Reba are the commercial picks for cell therapy, Asia-Pacific and cardiovascular and immunology.

Questions to take into the conversation

  1. 01How does Bristol Myers Squibb decide which early research programs earn a place in late-stage development?
  2. 02What does it take to build a supply chain for cell therapies that must reach patients on a fixed schedule?
  3. 03What should a technology or procurement partner show Bristol Myers Squibb before a pilot is expanded across the company?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Pharmaceuticals